0ET Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Esperion Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.601 EUR 64.41% Market Closed

Market Cap: €488.6m

E	Esperion Therapeutics Inc F:0ET	US
C	Credito Emiliano SpA F:EAO	IT
V	Veolia Environnement SA DUS:VVD	FR
	Zinc One Resources Inc XTSX:Z	CA
	Schneider Electric SE F:SNDB	FR

Profitability Summary

Esperion Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

61% > 68%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-229% > 15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-99%

Net Margin is Increasing

-295% > -6%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-69%

Free Cash Flow Margin is Increasing

-235% > -3%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-70%

ROIC is Increasing

-218% > 34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.